Myriad Genetics Inc
XETRA:MYD

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
XETRA:MYD
Watchlist
Price: 26.72 EUR 1.98%
Market Cap: 2.1B EUR

Wall Street
Price Targets

MYD Price Targets Summary
Myriad Genetics Inc

Wall Street analysts forecast MYD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MYD is 35.73 EUR with a low forecast of 15.36 EUR and a high forecast of 82.12 EUR.

Lowest
Price Target
15.36 EUR
43% Downside
Average
Price Target
35.73 EUR
34% Upside
Highest
Price Target
82.12 EUR
207% Upside
Myriad Genetics Inc Competitors:
Price Targets
PRME
Prime Medicine Inc
90% Upside
MDXH
MDxHealth SA
101% Upside
300685
Amoy Diagnostics Co Ltd
44% Upside
301047
Sino Biological Inc
18% Upside
ALKS
Alkermes Plc
60% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
68% Upside
ARMP
Armata Pharmaceuticals Inc
46% Upside
9926
Akeso Inc
53% Upside

Revenue
Forecast

Revenue Estimate
Myriad Genetics Inc

For the last 3 years the compound annual growth rate for Myriad Genetics Inc's revenue is 7%. The projected CAGR for the next 4 years is 4%.

7%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Myriad Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Myriad Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MYD's stock price target?
Price Target
35.73 EUR

According to Wall Street analysts, the average 1-year price target for MYD is 35.73 EUR with a low forecast of 15.36 EUR and a high forecast of 82.12 EUR.

What is Myriad Genetics Inc's Revenue forecast?
Projected CAGR
4%

For the last 3 years the compound annual growth rate for Myriad Genetics Inc's revenue is 7%. The projected CAGR for the next 4 years is 4%.

Back to Top